TIMP1 and breast cancer: In the past, TIMP-1 was considered to be a negative regulator of tumor metastasis, but more and more studies have found that high expression of TIMP-1 in NSCLC, colorectal cancer, breast cancer, gastric cancer, prostate cancer, endometrial cancer and so on often with poor prognosis [24].